Millennium Management Llc ownership in ER4 / Emergent BioSolutions Inc.

Emergent BioSolutions Inc.

DE ˙ DB ˙ US29089Q1058

6,75 € ↑0,05 (0,75%)

2026-06-04
AKTIENPREIS

Security	DE:ER4 / Emergent BioSolutions Inc.
Institution	Millennium Management Llc
Manager	Israel Englander
Latest Disclosed Ownership	2,095,662 shares
Ownership	4.00%

2024-01-18 - Millennium Management Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,095,662 shares of Emergent BioSolutions Inc. (DE:ER4). This represents 4.0 percent ownership of the company. In their previous filing dated 2023-09-07 , Millennium Management Llc had reported owning 2,711,399 shares, indicating a decrease of -22.71 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2024-01-18	2024-01-18	13G/A	2,711,399	2,095,662	-22.71	4.00	-23.08
2023-09-07	2023-09-07	13G		2,711,399		5.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	532,001	294,327	123.84	4,416	50.32	0.0018
2026-02-17	2025-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	237,674	159,850	205.40	2,938	328.13	0.0012
2025-11-14	2025-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	77,824	-677,608	-89.70	686	-85.76	0.0003
2025-08-14	2025-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	755,432	-1,747,056	-69.81	4,820	-60.38	0.0023
2025-05-15	2025-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,502,488	1,020,582	68.87	12,162	-14.15	0.0065
2025-02-14	2024-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,481,906	671,947	82.96	14,167	109.48	0.0069
2024-11-14	2024-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	809,959	-136,343	-14.41	6,763	4.80	0.0032
2024-08-14	2024-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	946,302	52,144	5.83	6,454	185.28	0.0030
2024-05-15	2024-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	894,158	-1,201,504	-57.33	2,262	-55.02	0.0010
2024-02-14	2023-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	2,095,662	-1,570,717	-42.84	5,030	-59.66	0.0022
2023-11-14	2023-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	3,666,379	2,384,105	185.93	12,466	32.27	0.0063
2023-08-14	2023-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	1,282,274	876,273	215.83	9,425	124.06	0.0046
2023-05-15	2023-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	406,001	406,001		4,206		0.0024
2023-02-14	2022-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	0	-70,326	-100.00	0	-100.00
2022-11-14	2022-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	70,326	-346,449	-83.13	1,476	-88.59	0.0009
2022-08-15	2022-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	416,775	-75,861	-15.40	12,937	-36.04	0.0080
2022-05-16	2022-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	492,636	92,268	23.05	20,228	16.23	0.0107
2022-02-14	2021-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	400,368	392,709	5,127.42	17,404	4,444.13	0.0088
2021-11-15	2021-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	7,659	814	11.89	383	-11.14	0.0002
2021-08-16	2021-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	6,845	1,987	40.90	431	-4.43	0.0003
2021-05-17	2021-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	4,858	-44,116	-90.08	451	-89.72	0.0003
2021-02-16	2020-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	48,974	-83,295	-62.97	4,388	-67.89	0.0032
2020-11-16	2020-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	132,269	127,333	2,579.68	13,667	3,404.36	0.0168
2020-08-14	2020-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	4,936	4,936		390		0.0005
2020-05-14	2020-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	0	-22,261	-100.00	0	-100.00
2020-02-14	2019-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	22,261	-352,248	-94.06	1,201	-93.87	0.0015
2019-11-14	2019-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	374,509	374,509		19,579		0.0310
2018-11-14	2018-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	0	-575,009	-100.00	0	-100.00
2018-08-14	2018-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	575,009	-342,056	-37.30	29,032	-39.87	0.0379
2018-05-15	2018-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	917,065	209,581	29.62	48,283	46.86	0.0644
2018-02-14	2017-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	707,484	64,321	10.00	32,877	26.37	0.0454
2017-11-14	2017-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	643,163	125,603	24.27	26,016	48.24	0.0396
2017-08-14	2017-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	517,560	-177,337	-25.52	17,550	-13.03	0.0313
2017-05-15	2017-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	694,897	548,780	375.58	20,180	320.59	0.0370
2017-02-14	2016-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	146,117	146,117		4,798		0.0100
2016-11-14	2016-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	0	-148,718	-100.00	0	-100.00
2016-08-15	2016-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	148,718	-22,839	-13.31	4,182	-32.94	0.0096
2016-05-16	2016-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	171,557	80,783	88.99	6,236	71.70	0.0156
2016-02-16	2015-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	90,774	7,779	9.37	3,632	53.57	0.0076
2015-11-16	2015-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	82,995	82,995	0.00	2,365		0.0046
2015-08-14	2015-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	0	-210,500	-100.00	0	-100.00
2015-05-15	2015-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	210,500	190,857	971.63	6,054	1,031.59	0.0113
2015-02-17	2014-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	19,643	3,943	25.11	535	59.70	0.0011
2014-11-14	2014-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	15,700	6,384	68.53	335	60.29	0.0008
2014-08-14	2014-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	9,316	-106,285	-91.94	209	-92.84	0.0006
2014-05-15	2014-03-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	115,601	3,418	3.05	2,921	13.26	0.0085
2014-02-14	2013-12-31	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	112,183	-25,509	-18.53	2,579	-1.68	0.0081
2013-11-14	2013-09-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	137,692	-231,533	-62.71	2,623	-50.73	0.0084
2013-08-14	2013-06-30	13F	EMERGENT BIOSOLUTIONS	COM	29089Q105	369,225	369,225		5,324		0.0163

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.